Evidence map›Paper›PMID 34864307›Full record

ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2022

Translation inhibition and suppression of stress granules formation by cisplatin.

Paulina Pietras, Anaïs Aulas, Marta M Fay, Marta Leśniczak-Staszak, Mateusz Sowiński, Shawn M Lyons, Witold Szaflarski, Pavel Ivanov

Open access · goldAbstract read
In one paragraph

Article in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Aurora-A drives sorafenib resistance by scaffolding stress granule assembly via phase separation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Paulina PietrasDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.
Anaïs AulasDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Marta M FayDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Marta Leśniczak-StaszakDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.
Mateusz SowińskiDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland.
Shawn M LyonsDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Witold SzaflarskiDepartment of Histology and Embryology, Poznan University of Medical Sciences, Poznań, Poland; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. Electronic address: witold@ump.edu.pl.
Pavel IvanovDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. Electronic address: pivanov@rics.bwh.harvard.edu.
Brigham and Women's Hospital · USPoznan University of Medical Sciences · PLHarvard University · US

Funding

Biology of RNA G-quadruplexesR01GM126150 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI IVANOV, PAVEL · 2019 to 2023
$1.9M
tRNA-derived stress-induced RNAs and translational controlR01GM146997 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI IVANOV, PAVEL · 2022 to 2025
$1.6M
Regulation of Ribosome Biogenesis During StressR00GM124458 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LYONS, SHAWN M · 2020 to 2022
$734k
G-quadruplex Structures as Targets and Tools in ALSR21NS094918 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI IVANOV, PAVEL · 2015 to 2016
$488k
Characterization of tiRNA-mediated Translational RepressionF32GM119283 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LYONS, SHAWN M · 2016 to 2017
$115k
NIGMS NIH HHS F32 GM119283NIGMS NIH HHS R00 GM124458NIGMS NIH HHS R01 GM126150NIGMS NIH HHS R01 GM146997NINDS NIH HHS R21 NS094918
6 · The paper itself

Abstract

Platinum-based antineoplastic drugs, such as cisplatin, are commonly used to induce tumor cell death. Cisplatin is believed to induce apoptosis as a result of cisplatin-DNA adducts that inhibit DNA and RNA synthesis. Although idea that DNA damage underlines anti-proliferative effects of cisplatin is dominant in cancer research, there is a poor correlation between the degree of the cell sensitivity to cisplatin and the extent of DNA platination. Here, we examined possible effects of cisplatin on post-transcriptional gene regulation that may contribute to cisplatin-mediated cytotoxicity. We show that cisplatin suppresses formation of stress granules (SGs), pro-survival RNA granules with multiple roles in cellular metabolism. Mechanistically, cisplatin inhibits cellular translation to promote disassembly of polysomes and aggregation of ribosomal subunits. As SGs are in equilibrium with polysomes, cisplatin-induced shift towards ribosomal aggregation suppresses SG formation. Our data uncover previously unknown effects of cisplatin on RNA metabolism.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorCells, CulturedCisplatinCytoplasmic Ribonucleoprotein GranulesHumansMiceProtein Processing, Post-TranslationalStress GranulesAntineoplastic AgentsCisplatinChemotherapyCisplatinStress granulesStress responseTranslation initiation

Identifiers

PMID34864307
PMCPMC8782064
OpenAlexW4200464496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.